GLP-1 treatment shows promise in curbing addiction Lifestyle March 5, 2026 London: Glucagon-like peptide-1 (GLP-1) receptor agonists, medications widely used to treat obesity and type 2 diabetes, may also help reduce…
12 years to rollout: Mounjaro weight-loss jab to transform obesity care Lifestyle December 5, 2024 United Kingdom: A groundbreaking weight-loss injection, Mounjaro, will soon be available on the NHS in England, but a full rollout…
